Vascular endothelial growth factor promotes the activation of hepatic stellate cells in chronic schistosomiasis

Jie Luo, Yuejin Liang, Fanping Kong, Jingfan Qiu, Xinjian Liu, Ailing Chen, Bruce A. Luxon, Hannah W. Wu, Yong Wang

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

The activation of hepatic stellate cells (HSCs) is a key event in fibrotic pathogenesis. However, the mechanism involving activation of HSCs in chronic schistosomiasis is not entirely clear. Human HSC LX-2 and human umbilical vein endothelial cells (ECs) were cultured with Schistosoma japonicum antigens (SA) in vitro. Fibrosis-associated genes and cell proliferation were analyzed. HSCs were isolated from mice of chronic schistosomiasis with or without praziquantel (PZQ) treatment, followed by the microarray analysis for the liver fibrosis-associated pathways. Although SA inhibited the activation and proliferation of HSCs, it induced the EC proliferation and vascular endothelial growth factor-a (VEGF) production. VEGF significantly increased the proliferation of HSCs and upregulated the expression of collagen and α-smooth muscle actin. For in vivo study, we found that several fibrosis-associated pathways were involved in the HSCs during the reversal of liver fibrosis caused by schistosomiasis, including VEGF, platelet-derived growth factor, tumor necrosis factor and endothelin-1 pathways. The Ingenuity Pathway Analysis showed that VEGF directly regulated several pro-fibrotic and immune cytokine genes in HSCs, including integrin, fibronectin, interferon-γ, interleukin (IL)-6 and IL-10. Our data indicated the critical role of VEGF signaling in HSC activation in chronic schistosomiasis and highlighted several promising genes and pathways in HSCs as potential targets for therapeutic treatment of liver fibrosis.Immunology and Cell Biology advance online publication, 3 January 2017; doi:10.1038/icb.2016.109.

Original languageEnglish (US)
JournalImmunology and Cell Biology
DOIs
StateAccepted/In press - Jan 3 2017

Fingerprint

Hepatic Stellate Cells
Schistosomiasis
Vascular Endothelial Growth Factor A
Liver Cirrhosis
Schistosoma japonicum
Fibrosis
Cell Proliferation
Genes
Antigens
Praziquantel
Platelet-Derived Growth Factor
Human Umbilical Vein Endothelial Cells
Endothelin-1
Microarray Analysis
Allergy and Immunology
Fibronectins
Integrins
Interleukin-10
Interferons
Smooth Muscle

ASJC Scopus subject areas

  • Immunology
  • Cell Biology

Cite this

Vascular endothelial growth factor promotes the activation of hepatic stellate cells in chronic schistosomiasis. / Luo, Jie; Liang, Yuejin; Kong, Fanping; Qiu, Jingfan; Liu, Xinjian; Chen, Ailing; Luxon, Bruce A.; Wu, Hannah W.; Wang, Yong.

In: Immunology and Cell Biology, 03.01.2017.

Research output: Contribution to journalArticle

Luo, Jie ; Liang, Yuejin ; Kong, Fanping ; Qiu, Jingfan ; Liu, Xinjian ; Chen, Ailing ; Luxon, Bruce A. ; Wu, Hannah W. ; Wang, Yong. / Vascular endothelial growth factor promotes the activation of hepatic stellate cells in chronic schistosomiasis. In: Immunology and Cell Biology. 2017.
@article{789cfc9c69944697a55282db945d95d4,
title = "Vascular endothelial growth factor promotes the activation of hepatic stellate cells in chronic schistosomiasis",
abstract = "The activation of hepatic stellate cells (HSCs) is a key event in fibrotic pathogenesis. However, the mechanism involving activation of HSCs in chronic schistosomiasis is not entirely clear. Human HSC LX-2 and human umbilical vein endothelial cells (ECs) were cultured with Schistosoma japonicum antigens (SA) in vitro. Fibrosis-associated genes and cell proliferation were analyzed. HSCs were isolated from mice of chronic schistosomiasis with or without praziquantel (PZQ) treatment, followed by the microarray analysis for the liver fibrosis-associated pathways. Although SA inhibited the activation and proliferation of HSCs, it induced the EC proliferation and vascular endothelial growth factor-a (VEGF) production. VEGF significantly increased the proliferation of HSCs and upregulated the expression of collagen and α-smooth muscle actin. For in vivo study, we found that several fibrosis-associated pathways were involved in the HSCs during the reversal of liver fibrosis caused by schistosomiasis, including VEGF, platelet-derived growth factor, tumor necrosis factor and endothelin-1 pathways. The Ingenuity Pathway Analysis showed that VEGF directly regulated several pro-fibrotic and immune cytokine genes in HSCs, including integrin, fibronectin, interferon-γ, interleukin (IL)-6 and IL-10. Our data indicated the critical role of VEGF signaling in HSC activation in chronic schistosomiasis and highlighted several promising genes and pathways in HSCs as potential targets for therapeutic treatment of liver fibrosis.Immunology and Cell Biology advance online publication, 3 January 2017; doi:10.1038/icb.2016.109.",
author = "Jie Luo and Yuejin Liang and Fanping Kong and Jingfan Qiu and Xinjian Liu and Ailing Chen and Luxon, {Bruce A.} and Wu, {Hannah W.} and Yong Wang",
year = "2017",
month = "1",
day = "3",
doi = "10.1038/icb.2016.109",
language = "English (US)",
journal = "Immunology and Cell Biology",
issn = "0818-9641",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Vascular endothelial growth factor promotes the activation of hepatic stellate cells in chronic schistosomiasis

AU - Luo, Jie

AU - Liang, Yuejin

AU - Kong, Fanping

AU - Qiu, Jingfan

AU - Liu, Xinjian

AU - Chen, Ailing

AU - Luxon, Bruce A.

AU - Wu, Hannah W.

AU - Wang, Yong

PY - 2017/1/3

Y1 - 2017/1/3

N2 - The activation of hepatic stellate cells (HSCs) is a key event in fibrotic pathogenesis. However, the mechanism involving activation of HSCs in chronic schistosomiasis is not entirely clear. Human HSC LX-2 and human umbilical vein endothelial cells (ECs) were cultured with Schistosoma japonicum antigens (SA) in vitro. Fibrosis-associated genes and cell proliferation were analyzed. HSCs were isolated from mice of chronic schistosomiasis with or without praziquantel (PZQ) treatment, followed by the microarray analysis for the liver fibrosis-associated pathways. Although SA inhibited the activation and proliferation of HSCs, it induced the EC proliferation and vascular endothelial growth factor-a (VEGF) production. VEGF significantly increased the proliferation of HSCs and upregulated the expression of collagen and α-smooth muscle actin. For in vivo study, we found that several fibrosis-associated pathways were involved in the HSCs during the reversal of liver fibrosis caused by schistosomiasis, including VEGF, platelet-derived growth factor, tumor necrosis factor and endothelin-1 pathways. The Ingenuity Pathway Analysis showed that VEGF directly regulated several pro-fibrotic and immune cytokine genes in HSCs, including integrin, fibronectin, interferon-γ, interleukin (IL)-6 and IL-10. Our data indicated the critical role of VEGF signaling in HSC activation in chronic schistosomiasis and highlighted several promising genes and pathways in HSCs as potential targets for therapeutic treatment of liver fibrosis.Immunology and Cell Biology advance online publication, 3 January 2017; doi:10.1038/icb.2016.109.

AB - The activation of hepatic stellate cells (HSCs) is a key event in fibrotic pathogenesis. However, the mechanism involving activation of HSCs in chronic schistosomiasis is not entirely clear. Human HSC LX-2 and human umbilical vein endothelial cells (ECs) were cultured with Schistosoma japonicum antigens (SA) in vitro. Fibrosis-associated genes and cell proliferation were analyzed. HSCs were isolated from mice of chronic schistosomiasis with or without praziquantel (PZQ) treatment, followed by the microarray analysis for the liver fibrosis-associated pathways. Although SA inhibited the activation and proliferation of HSCs, it induced the EC proliferation and vascular endothelial growth factor-a (VEGF) production. VEGF significantly increased the proliferation of HSCs and upregulated the expression of collagen and α-smooth muscle actin. For in vivo study, we found that several fibrosis-associated pathways were involved in the HSCs during the reversal of liver fibrosis caused by schistosomiasis, including VEGF, platelet-derived growth factor, tumor necrosis factor and endothelin-1 pathways. The Ingenuity Pathway Analysis showed that VEGF directly regulated several pro-fibrotic and immune cytokine genes in HSCs, including integrin, fibronectin, interferon-γ, interleukin (IL)-6 and IL-10. Our data indicated the critical role of VEGF signaling in HSC activation in chronic schistosomiasis and highlighted several promising genes and pathways in HSCs as potential targets for therapeutic treatment of liver fibrosis.Immunology and Cell Biology advance online publication, 3 January 2017; doi:10.1038/icb.2016.109.

UR - http://www.scopus.com/inward/record.url?scp=85008395183&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85008395183&partnerID=8YFLogxK

U2 - 10.1038/icb.2016.109

DO - 10.1038/icb.2016.109

M3 - Article

AN - SCOPUS:85008395183

JO - Immunology and Cell Biology

JF - Immunology and Cell Biology

SN - 0818-9641

ER -